Orientin

• Description:

  Orientin may be regarded as a candidate therapeutic agent for treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  448.38

• Molecular Formula:

  C21H20O11

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  28608-75-5